Papers
3
Total Citations
133
H-Index
2
About
Ken Lund is a clinical researcher whose work centers on gynecologic oncology, with a particular focus on the surgical management of endometrial cancer. His most significant contributions examine the real-world impact of transitioning from traditional open surgery to minimally invasive robotic surgery (MILS) for women diagnosed with early-stage endometrial cancer — a shift with profound implications for patient outcomes and healthcare delivery. Lund's most influential research emerged from large-scale Danish population-based studies that evaluated the nationwide introduction of robotic surgery. His 2019 paper on severe complications, which has garnered 69 citations, demonstrated how expanding access to minimally invasive approaches could meaningfully reduce surgical morbidity for endometrial cancer patients. A companion study from the same year, with 62 citations, extended this work by examining survival outcomes, providing critical evidence that robotic surgery did not compromise oncological efficacy while improving safety profiles. What distinguishes Lund's research is its population-level scope — leveraging national registry data to move beyond small clinical trials and assess outcomes across an entire healthcare system. His findings have contributed to evidence-based policy discussions around surgical best practices in gynecologic oncology, helping establish robotic minimally invasive surgery as a viable and beneficial standard of care for early-stage endometrial cancer patients.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3